Hydroxyurea-Induced Pneumopathy in a Patient With Myeloproliferative Syndrome

Hydroxyurea (HU) is a drug frequently used in the treatment of chronic myeloproliferative neoplasms. The most common side effects of this drug are pancytopenia, digestive and skin disorders. Respiratory complications are rare and there are less than 20 cases described, only 5 of which underwent an a...

Descripción completa

Detalles Bibliográficos
Autores principales: Galván, Oriol Plans, Moltó, Hipólito Pérez, Fabià-Mayans, Ariadna, Xicoy, Blanca, Mate, José Luis, Martí, Pilar Ricart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993068/
https://www.ncbi.nlm.nih.gov/pubmed/29899671
http://dx.doi.org/10.1177/1179547618770688
_version_ 1783330169090473984
author Galván, Oriol Plans
Moltó, Hipólito Pérez
Fabià-Mayans, Ariadna
Xicoy, Blanca
Mate, José Luis
Martí, Pilar Ricart
author_facet Galván, Oriol Plans
Moltó, Hipólito Pérez
Fabià-Mayans, Ariadna
Xicoy, Blanca
Mate, José Luis
Martí, Pilar Ricart
author_sort Galván, Oriol Plans
collection PubMed
description Hydroxyurea (HU) is a drug frequently used in the treatment of chronic myeloproliferative neoplasms. The most common side effects of this drug are pancytopenia, digestive and skin disorders. Respiratory complications are rare and there are less than 20 cases described, only 5 of which underwent an anatomopathological study. We present the case of a patient with chronic myeloproliferative neoplasm who developed interstitial pneumonitis probably due to HU according to histological study.
format Online
Article
Text
id pubmed-5993068
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-59930682018-06-13 Hydroxyurea-Induced Pneumopathy in a Patient With Myeloproliferative Syndrome Galván, Oriol Plans Moltó, Hipólito Pérez Fabià-Mayans, Ariadna Xicoy, Blanca Mate, José Luis Martí, Pilar Ricart Clin Med Insights Case Rep Case Report Hydroxyurea (HU) is a drug frequently used in the treatment of chronic myeloproliferative neoplasms. The most common side effects of this drug are pancytopenia, digestive and skin disorders. Respiratory complications are rare and there are less than 20 cases described, only 5 of which underwent an anatomopathological study. We present the case of a patient with chronic myeloproliferative neoplasm who developed interstitial pneumonitis probably due to HU according to histological study. SAGE Publications 2018-04-23 /pmc/articles/PMC5993068/ /pubmed/29899671 http://dx.doi.org/10.1177/1179547618770688 Text en © The Author(s) 2018 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Case Report
Galván, Oriol Plans
Moltó, Hipólito Pérez
Fabià-Mayans, Ariadna
Xicoy, Blanca
Mate, José Luis
Martí, Pilar Ricart
Hydroxyurea-Induced Pneumopathy in a Patient With Myeloproliferative Syndrome
title Hydroxyurea-Induced Pneumopathy in a Patient With Myeloproliferative Syndrome
title_full Hydroxyurea-Induced Pneumopathy in a Patient With Myeloproliferative Syndrome
title_fullStr Hydroxyurea-Induced Pneumopathy in a Patient With Myeloproliferative Syndrome
title_full_unstemmed Hydroxyurea-Induced Pneumopathy in a Patient With Myeloproliferative Syndrome
title_short Hydroxyurea-Induced Pneumopathy in a Patient With Myeloproliferative Syndrome
title_sort hydroxyurea-induced pneumopathy in a patient with myeloproliferative syndrome
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993068/
https://www.ncbi.nlm.nih.gov/pubmed/29899671
http://dx.doi.org/10.1177/1179547618770688
work_keys_str_mv AT galvanoriolplans hydroxyureainducedpneumopathyinapatientwithmyeloproliferativesyndrome
AT moltohipolitoperez hydroxyureainducedpneumopathyinapatientwithmyeloproliferativesyndrome
AT fabiamayansariadna hydroxyureainducedpneumopathyinapatientwithmyeloproliferativesyndrome
AT xicoyblanca hydroxyureainducedpneumopathyinapatientwithmyeloproliferativesyndrome
AT matejoseluis hydroxyureainducedpneumopathyinapatientwithmyeloproliferativesyndrome
AT martipilarricart hydroxyureainducedpneumopathyinapatientwithmyeloproliferativesyndrome

Ejemplares similares